JONAH MCINTYRE: Open Payments
NPI 1699752303 · ATMORE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 13 payments from 10 companies in 2025. Trend: 2023 $305 · 2024 $354 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 1 | $32 |
| Novo Nordisk Inc | 2 | $30 |
| Lilly USA, LLC | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $27 |
| PFIZER INC. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| SHIELD THERAPEUTICS INC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
Products named: LEQEMBI, Ozempic, MOUNJARO, ELIQUIS, INGREZZA, ACCRUFER, CAPLYTA, ZORYVE.
Industry payments across AL — which companies pay providers there.
